491
|
|
|
Formyl peptide receptor 2 |
ALX, ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH1, FPRH2, FPRL1, HM63, LXA4R |
|
492
|
|
|
Formyl peptide receptor 3 |
FML2_HUMAN, FMLP-R-II, FMLPY, FPRH1, FPRH2, FPRL2, RMLP-R-I |
|
493
|
|
|
FRA10A associated CGG repeat 1 |
C10orf4, F26C11.1-like, FRA10A, NEDGFC |
|
494
|
|
|
Fraser extracellular matrix complex subunit 1 |
FRASRS1 |
|
495
|
|
|
FRAT regulator of Wnt signaling pathway 1 |
- |
|
496
|
|
|
FRAT regulator of Wnt signaling pathway 2 |
FRAT-2 |
|
497
|
|
|
FRAS1 related extracellular matrix 1 |
BNAR, C9orf143, C9orf145, C9orf154, MOTA, TILRR, TRIGNO2 |
Bifid nose, Bnar syndrome, Congenital anomalies of the kidney and urinary tract, Cardiovascular disease, Kidney disease, Lymphocytic leukemia, Congenital diaphragmatic hernia, Craniosynostosis, Eye abnormalities, Craniofaciosynostosis, Metabolic syndrome, Willis-ekbom disease, Trigonocephaly, Diabetes mellitus type 2 |
498
|
|
|
FRAS1 related extracellular matrix 2 |
CRYPTOP, FRASRS2 |
Ambiguous genitalia, Congenital anomalies of the kidney and urinary tract, Cryptophthalmia, Congenital diaphragmatic hernia, Cryptophthalmos syndrome, Cryptotria, Epidermolysis bullosa, Fraser syndrome, Psoriasis, Schizophrenia, Syndactyly |
499
|
|
|
FRAS1 related extracellular matrix 3 |
- |
|
500
|
|
|
Frey regulator of sperm-oocyte fusion 1 |
C11orf94, Frey |
|